What each test is, why a doctor may consider it, what it feels like, what results can and cannot show, and questions to ask. For learning only: OncoGx™ never orders tests.
A small amount of a radioactive tracer shows areas of high activity, combined with CT to show where they are.
Typical turnaround
Usually a few days.
Preparation
Usually fasting for several hours; special instructions for people with diabetes.
Ordering
Only a clinician can decide if this test is right for you.
A tracer (often a type of sugar called FDG) is injected. Cells that use more energy, including many cancer cells, take up more tracer and show up on the scan.
Doctors may consider this test:
To stage some cancers and see whether they have spread
To check response to treatment in some cancers such as lymphoma
To investigate specific questions after other scans
You rest quietly for about an hour after the injection, then the scan takes 20 to 45 minutes. Drink plenty afterwards.
Preparation: Usually fasting for several hours; special instructions for people with diabetes.
What results can show
Show active areas across the whole body
Help distinguish scar tissue from active disease in some situations
What results cannot show
Replace a biopsy
Tell infection or inflammation apart from cancer reliably
What question will this PET scan answer?
Do I need to fast or adjust diabetes medicines?
Should I avoid close contact with babies or pregnant people afterwards?
Two different things: inherited (germline) tests from blood or saliva, and tumour (somatic) tests on the cancer itself.
Typical turnaround
Often two to six weeks.
Preparation
Genetic counselling is recommended before germline testing.
Ordering
Only a clinician can decide if this test is right for you.
Germline tests look for inherited gene changes that raise risk in a family, such as BRCA1 or BRCA2. Tumour tests look for changes inside cancer cells that can guide treatment.
Doctors may consider this test:
To check inherited risk when family history suggests it
To find tumour changes that match a targeted treatment or a clinical trial
Germline: a blood or saliva sample, usually after genetic counselling. Tumour: uses tissue already taken at biopsy or surgery.
Preparation: Genetic counselling is recommended before germline testing.
What results can show
Guide screening and prevention for families with an inherited change
Match some cancers to targeted treatments
What results cannot show
Predict for certain whether someone will get cancer
Results can show variants of uncertain significance
Consumer tests are not a substitute for clinical testing with counselling
Consent and privacy: Genetic results can affect relatives and, in some countries, insurance. Ask about consent, data storage and who will see the results before testing.
Blood tests that look for tumour signals in the bloodstream, such as circulating tumour DNA (ctDNA) and circulating tumour cells (CTCs).
Typical turnaround
Usually one to three weeks.
Preparation
Usually none.
Ordering
Only a clinician can decide if this test is right for you.
Tumours can shed tiny amounts of their DNA, and sometimes whole cells, into the blood. A liquid biopsy looks for these signals in an ordinary blood sample. Different tests look for different signals, and each has its own uses and limits.
What a liquid biopsy can look for
Circulating tumour DNA (ctDNA)Fragments of tumour DNA mixed in with the normal cell-free DNA (cfDNA) in plasma. Used to look for treatment-guiding gene changes and, in trials, leftover disease after treatment.
Circulating tumour cells (CTCs)Whole cancer cells that have broken away from a tumour into the blood. They are very rare, often a few among billions of blood cells. Counting them can help estimate outlook in some advanced cancers, and they can be studied for markers.
DNA methylation and fragment patternsChemical tags and fragment sizes on cell-free DNA that differ between cancer and healthy cells. Many multi-cancer early detection tests use these.
Other signalsTumour proteins, RNA and tiny vesicles called exosomes. These are mostly still being researched.
Doctors may consider this test:
To find treatment-guiding gene changes (ctDNA) in some advanced cancers when tissue is hard to get (an established use)
To count circulating tumour cells (CTCs) as a guide to outlook in some advanced breast, prostate and bowel cancers (a specialist use)
To look for leftover disease after treatment (emerging, mostly in trials)
Multi-cancer early detection in people without symptoms (investigational)
A standard blood draw, sometimes into special tubes that keep DNA or cells stable until they reach the lab.
Preparation: Usually none.
What results can show
Guide treatment in some advanced cancers
Avoid a repeat tissue biopsy in some situations
What results cannot show
Diagnose cancer: a positive signal needs scans and a tissue biopsy
Rule cancer out: early detection tests miss many cancers
Replace recommended screening such as mammography, bowel or cervical screening
Which job is this test being used for: treatment matching, monitoring or screening?
What happens if the result is positive, and who will arrange follow-up?
Is this test part of standard care or a trial where I live?
Some things apply to almost every test on this page.
What doctors may consider
Which test is used depends on the question being asked, your symptoms, history, local guidelines and what is available. The same symptom can lead to different tests for different people, and that is normal.
Consent and privacy
You can ask why a test is recommended, what the alternatives are, and what happens if you wait. For genetic tests and research samples, ask how your data is stored and who can see it. You can take time to decide.
Turnaround times
Results can take anything from the same day to several weeks. Biopsy and genomic results usually take longest. Ask when to expect results and who to call if you have not heard.
Questions to ask before testing
What question will this test answer?
What are the benefits and limitations for me?
What happens if the result is unclear?
How and when will I get the result?
Is there one blood test that can find all cancers?
Not yet. Multi-cancer early detection blood tests are being studied in large trials. They can miss many cancers, can give false alarms, and have not been shown to reduce cancer deaths. They do not replace recommended screening. Watch our interactive video Can one blood test find cancer early?
Can a biopsy make cancer spread?
This is a common worry. With modern techniques, the risk is very small, and doctors take steps to reduce it. A biopsy is usually the only way to confirm a diagnosis and plan the right treatment. Ask your team how they minimise any risk for your type of biopsy.